These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8905180)

  • 1. Increased iron in the substantia nigra of 6-OHDA induced parkinsonian rats: a nuclear microscopy study.
    He Y; Thong PS; Lee T; Leong SK; Shi CY; Wong PT; Yuan SY; Watt F
    Brain Res; 1996 Sep; 735(1):149-53. PubMed ID: 8905180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
    J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-course and localization of transferrin receptor expression in the substantia nigra of 6-hydroxydopamine-induced parkinsonian rats.
    He Y; Lee T; Leong SK
    Neuroscience; 1999; 91(2):579-85. PubMed ID: 10366015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The protective effect of ginsenoside Rg1 on dopaminergic neurons of substantia in the ovariectomized rat model of Parkinson's disease].
    Xu L; Liu LX; Chen WF; Xie JX; Huang WX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):1-5. PubMed ID: 21141541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of lentivirus-mediated cystathionine-beta-synthase overexpression against 6-OHDA-induced parkinson's disease rats.
    Yin WL; Yin WG; Huang BS; Wu LX
    Neurosci Lett; 2017 Sep; 657():45-52. PubMed ID: 28764908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron accumulation and microglia activation contribute to substantia nigra hyperechogenicity in the 6-OHDA-induced rat model of Parkinson's disease.
    Zhu Y; Wang B; Tao K; Yang H; Wang Y; Zhou T; Yang Y; Yuan L; Liu X; Duan Y
    Parkinsonism Relat Disord; 2017 Mar; 36():76-82. PubMed ID: 28108264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
    Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of dopaminergic cell death and changes in iron, ferritin and transferrin levels in the rat substantia nigra after 6-hydroxydopamine (6-OHDA) lesioning.
    He Y; Lee T; Leong SK
    Free Radic Res; 1999 Aug; 31(2):103-12. PubMed ID: 10490239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron accumulation in the substantia nigra in rats visualized by ultrasound.
    Berg D; Grote C; Rausch WD; Mäurer M; Wesemann W; Riederer P; Becker G
    Ultrasound Med Biol; 1999 Jul; 25(6):901-4. PubMed ID: 10461717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
    Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
    Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats.
    Wang J; Jiang H; Xie JX
    Eur J Neurosci; 2007 May; 25(9):2766-72. PubMed ID: 17561842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].
    Meng JL; Ma YY; Luo HY; Kong SZ; He YW; Dong BC; Wu SH; He M
    Sheng Li Xue Bao; 2008 Jun; 60(3):369-74. PubMed ID: 18560728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrastriatal implantation of interleukin-1. Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain.
    Wang J; Bankiewicz KS; Plunkett RJ; Oldfield EH
    J Neurosurg; 1994 Mar; 80(3):484-90. PubMed ID: 7906726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceruloplasmin is Involved in the Nigral Iron Accumulation of 6-OHDA-Lesioned Rats.
    Wang J; Bi M; Xie J
    Cell Mol Neurobiol; 2015 Jul; 35(5):661-8. PubMed ID: 25656940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
    Perlbarg V; Lambert J; Butler B; Felfli M; Valabrègue R; Privat AL; Lehéricy S; Petiet A
    PLoS One; 2018; 13(9):e0202597. PubMed ID: 30188909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional distributions of manganese, iron, copper, and zinc in the brains of 6-hydroxydopamine-induced parkinsonian rats.
    Tarohda T; Ishida Y; Kawai K; Yamamoto M; Amano R
    Anal Bioanal Chem; 2005 Sep; 383(2):224-34. PubMed ID: 16132122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplanted Neural Stem Cells: Playing a Neuroprotective Role by Ceruloplasmin in the Substantia Nigra of PD Model Rats?
    Xiao JJ; Yin M; Wang ZJ; Wang XP
    Oxid Med Cell Longev; 2015; 2015():618631. PubMed ID: 26146528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
    J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.